Oxidation of antidiabetic compounds by cytochrome P450 BM3
Jeffreys, L., Leys, D., Munro, A.W.M.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
Macromolecule Content 
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Bifunctional cytochrome P450/NADPH--P450 reductase | 457 | Priestia megaterium | Mutation(s): 2  Gene Names: BTA37_15100 EC: 1.14.14.1 (PDB Primary Data), 1.6.2.4 (PDB Primary Data) | ![]() | |
UniProt | |||||
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | P14779 | ||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
| Ligands 2 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| HEM Download:Ideal Coordinates CCD File | C [auth A], E [auth B] | PROTOPORPHYRIN IX CONTAINING FE C34 H32 Fe N4 O4 KABFMIBPWCXCRK-RGGAHWMASA-L | |||
| TDZ (Subject of Investigation/LOI) Download:Ideal Coordinates CCD File | D [auth A], F [auth B] | (5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE C24 H27 N O5 S GXPHKUHSUJUWKP-NTKDMRAZSA-N | |||
| Length ( Å ) | Angle ( ˚ ) |
|---|---|
| a = 60.905 | α = 90 |
| b = 120.375 | β = 90 |
| c = 145.951 | γ = 90 |
| Software Name | Purpose |
|---|---|
| PHENIX | refinement |
| XDS | data reduction |
| XDS | data scaling |
| PHASER | phasing |